Application advances in cellular immunotherapy for acute leukemia / 白血病·淋巴瘤

ABSTRACT

Acute leukemia is the most common hematological malignancies.Based on the development of chemotherapy drugs and the improvement of chemotherapy regimens,the remission rate after induction chemotherapy increases obviously.But leukemia patients can not live for a long time mainly because of the ease relapse,so how to extend remission after treatment become the key to solve the problem.People are paying more and more attention on the cellular immunotherapy since it playes major roles in eradicating minimal residual disease of leukemia,reducing leukemia relapse and improving leukemia patients overall survival.This article reviews the application advances in research on this subject.